Page 5 of 6
Organic & Biomolecular Chemistry
Please do not adjust margins
Journal Name
ARTICLE
CDCl3) δ -66.19(s, 3F); GC-MS (EI, m/z): 214(M+, 100), 186(57), 66.34 (s, 3F); GC-MS (EI, m/z): 292(M+, 71), 294V(7ie0w)A, rt1ic5le7O(n8l9in)e,
136(52), 63(34).
87(100).
6-Nitro-3-(trifluoromethyl)-2H-1-Benzopyran-2-one
DOI: 10.1039/C5OB01516B
(2i)16.
6-Methyl-3-(trifluoromethyl)-2H-1-Benzopyran-2-one
(2b)16.
1
White powder (51.0mg, 56%); mp 122-123 °C; 1H NMR (500 MHz,
CDCl3) δ 8.11 (s, 1H), 7.48 (d, J = 8.4 Hz, 1H), 7.40 (s, 1H), 7.28 (d, J =
8.3 Hz, 1H), 2.44 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 155.19 (s),
151.73 (s), 142.38 (q, J = 4.8 Hz), 134.56 (s), 134.24 (s), 128.14 (s),
120.42 (q, J = 271.9 Hz), 116.38 (q, J = 33.3 Hz), 115.65 (s), 115.48
(s), 19.67 (s); 19F NMR (470 MHz, CDCl3) δ -66.13 (s, 3F); GC–MS (EI,
m/z): 228(M+, 100), 200(48), 199(43), 131(43).
Yellow powder (41.6mg, 39%); mp 188-189 °C; H NMR (500 MHz,
CDCl3) δ 8.58 (d, J = 2.6 Hz, 1H), 8.54 (dd, J = 9.1, 2.6 Hz, 1H), 8.26 (s,
1H), 7.56 (d, J = 9.1 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 157.80 (s),
154.15 (s), 144.43 (s), 142.07 (q, J = 4.9 Hz), 128.85 (s), 125.24 (s),
120.66 (q, J = 272.9 Hz), 120.05 (q, J = 34.1 Hz), 118.40 (s), 116.77
(s); 19F NMR (470 MHz, CDCl3) δ -66.51 (s); GC-MS (EI, m/z): 256(M+,
59), 157(100), 87(83), 62(55).
22
4-Phenyl-3-(trifluoromethyl)-2H-1-Benzopyran-2-one (2J)16,
.
8-Methyl-3-(trifluoromethyl)-2H-1-Benzopyran-2-one
(2c)16.
1
1
White powder (57.5 mg, 50%); mp: 132-133°C; H NMR (500 MHz,
CDCl3) δ 7.66 -7.59 (m, 1H), 7.57 – 7.51 (m, 3H), 7.41 (d, J = 8.3 Hz,
1H), 7.28 - 7.24 (m, 2H), 7.21 (t, J = 7.7 Hz, 1H), 7.02 (d, J = 8.1 Hz,
1H); 13C NMR (126 MHz, CDCl3) δ 156.85 (d, J = 2.1 Hz), 156.37 (s),
153.38 (s), 134.09 (s), 132.79 (s), 129.26 (d, J = 5.5 Hz), 128.46 (s),
127.23 (d, J = 1.6 Hz), 124.76 (s), 121.82 (q, J = 275.3 Hz), 119.43 (s),
116.82 (s), 114.98 (q, J = 30.3 Hz); 19F NMR (470 MHz, CDCl3) δ -
57.46 (s); GC-MS (EI, m/z): 190(M+, 71), 262(63), 165(100), 82(38).
White powder (52.9 mg, 58%), mp 121-122 °C; H NMR (500 MHz,
CDCl3): δ 8.14 (s, 1H), 7.53 (d, J = 7.5 Hz, 1H), 7.45 (d, J = 7.6 Hz, 1H),
7.28 (t, J = 7.6 Hz, 1H), 2.48 (s, 3H); 13C NMR (126 MHz, CDCl3) δ
156.06 (s), 153.02 (s), 143.64 (q, J = 4.9 Hz), 135.68 (s), 127.12 (s),
126.70 (s), 124.81 (s), 121.44 (q, J = 271.9 Hz), 117.33 (q, J = 33.3
Hz), 116.55 (s), 15.36 (s); 19F NMR (470 MHz, CDCl3) δ -66.10 (s, 3F).
GC-MS (EI, m/z): 228(M+, 100), 200(54), 199(52), 131(95).
6,8-Dimethyl-3-(trifluoromethyl)-2H-1-Benzopyran-2-one (2d).
1
7-(Diethylamino)-4-methyl-3-(trifluoromethyl)-2H-1-Benzopy-
White powder (57.4mg, 60%); mp 126-127 °C; H NMR (500 MHz,
1
ran-2-one (2k)23. Yellow powder (86.2 mg, 71%); mp: 92-93 °C; H
CDCl3) δ 8.07 (s, 1H), 7.34 (s, 1H), 7.22 (s, 1H), 2.44 (s, 3H), 2.40 (s,
3H); 13C NMR (126 MHz, CDCl3) δ 156.26 (s), 151.24 (s), 143.56 (q, J
= 4.8 Hz), 136.90 (s), 134.60 (s), 126.77 (s), 126.30 (s), 121.55 (q, J =
271.8 Hz), 117.19 (q, J = 32.8 Hz), 116.37 (s), 20.59 (s), 15.23 (s); 19F
NMR (470 MHz, CDCl3) δ -66.20 (s, 3F); HRMS (ESI) m/z: [M+Na]+
Calcd. For C12H9F3O2Na 265.0452; found 265.0456.
NMR (500 MHz, CDCl3) δ 7.56 (d, J = 9.2 Hz, 1H), 6.64 (dd, J = 9.2,
2.1 Hz, 1H), 6.45 (d, J = 2.2 Hz, 1H), 3.44 (q, J = 7.1 Hz, 4H), 2.56 (d, J
= 2.0 Hz, 3H), 1.23 (t, J = 7.1 Hz, 6H); 13C NMR (126 MHz, CDCl3) δ
157.39 (d, J = 0.7 Hz), 155.95 (s), 155.06 (d, J = 0.6 Hz), 151.98 (s),
127.22 (s), 123.84 (q, J = 274.0 Hz), 109.39 (s), 108.02 (s), 107.97 (q,
J = 30.2 Hz), 96.92 (s), 44.96 (s), 15.31 (s), 12.50 (s); 19F NMR (470
MHz, CDCl3) δ -55.47 (s); GC-MS (EI, m/z): 299(M+, 34), 284(100),
256(43).
6-tert-Butyl-3-(trifluoromethyl)-2H-1-Benzopyran-2-one (2e).
1
White powder (71.2 mg, 66%); mp 162-163 °C; H NMR (400 MHz,
CDCl3) δ 8.11 (s, 1H), 7.66 (dd, J = 8.8, 2.2 Hz, 1H), 7.51 (d, J = 2.2 Hz,
1H), 7.26 (d, J = 8.8 Hz, 1H), 1.29 (s, 9H); 13C NMR (100 MHz, CDCl3)
δ 156.26 (s), 152.63 (s), 148.57 (s), 143.84 (q, J = 4.5 Hz), 132.25 (s),
125.67 (s), 121.53 (q, J =271.3 Hz), 117.25 (q, J = 32.9 Hz), 116.51
(s), 116.20 (s), 34.61 (s), 31.18 (s); 19F NMR (377 MHz, CDCl3) δ -
66.56 (s, 3F); HRMS (ESI) m/z: [M+Na]+ Calcd. For C14H13F3O2Na
293.0765; found 293.0759.
Acknowledgements
This work was supported by the National Natural Science
Foundation of China (NSFC) (ProJect Nos. 21176039 and 20923006).
7-Methoxyl-3-(trifluoromethyl)-2H-1-Benzopyran-2-one (2f)16.
White powder (60.5 mg, 63%); mp 124-125 °C; H NMR (500 MHz,
Notes and references
1
1. Z. P. Li, J. P. Hu, M. N. Sun, H. J. Ji, S. F. Chu, G. Liu and N. H.
Chen, Int. Immunopharm., 2012, 14, 145.
CDCl3) δ 8.08 (s, 1H), 7.51 (d, J = 8.7 Hz, 1H), 6.93 (dd, J = 8.7, 2.4 Hz,
1H), 6.85 (d, J = 2.3 Hz, 1H), 3.92 (s, 3H); 13C NMR (100 MHz, CDCl3)
δ 164.93 (s), 156.78 (s), 156.36 (s), 143.22 (q, J = 4.2 Hz), 130.53 (s),
121.67 (q, J = 277.7 Hz), 113.74 (s), 113.71 (q, J = 33.6 Hz), 110.31
(s), 100.67 (s), 56.00 (s); 19F NMR (470 MHz, CDCl3) δ -65.68 (s, 3F);
GC-MS (EI, m/z): 244(M+, 78), 216(73), 201 (100), 69(40).
2. (a) L. M. Kabeya, C. N. Fuzissaki, S. H. Taleb-Contini, C. F. A. M.
da, Z. Naal, E. O. Santos, A. S. Figueiredo-Rinhel, A. E. Azzolini,
R. B. Vermelho, A. Malvezzi, A. T. Amaral, J. L. Lopes and Y. M.
Lucisano-Valim, Chem. Biol. Interact., 2013, 206, 63; (b) K. N.
Venugopala, V. Rashmi and B. Odhav, Bio. Med. Res. Int., 2013,
963248.
3. (a) W. W. Yu, H. H. Wang, H. J. Ying, Y. Yu, D. D. Chen, W. H. Ge
and L. Y. Shi, Int. Immunopharm., 2014, 21, 1; (b) A. Witaicenis,
L. N. Seito, A. da Silveira Chagas, L. D. de Almeida, A. C. Luchini,
P. Rodrigues-Orsi, S. H. Cestari and L. C. Di Stasi, Phytomedicine,
2014, 21, 240; (c) Z. Gao, Q. P. Wen, Y. Xia, J. X Yang, P. Gao, N.
Zhang, H. Y. Li and S. F. Zou, J. Pharm. Sci., 2014, 124, 54.
4. (a) G. L. Xi and Z. Q. Liu, Eur. J. Med. Chem., 2013, 68, 385; (b) J.
M. Li, X. Zhang, X. Wang, Y. C. Xie and L. D. Kong, Eur. J. Pharm.,
2011, 666, 196.
7-Acetyloxy-3-(trifluoromethyl)-2H-1-Benzopyran-2-one (2g)16.
1
White powder (64.1 mg, 59%); mp 146-147 °C; H NMR (500 MHz,
CDCl3) δ 8.15 (s, 1H), 7.64 (d, J = 8.5 Hz, 1H), 7.21 (d, J = 2.0 Hz, 1H),
7.17 (dd, J = 8.5, 2.1 Hz, 1H), 2.37 (s, 3H); 13C NMR (126 MHz, CDCl3)
δ 168.32 (s), 155.55 (d, J = 0.6 Hz), 155.33 (s), 155.18 (s), 142.74 (q,
J = 4.8 Hz), 130.30 (s), 121.28 (q, J = 272.0 Hz), 119.34 (s), 116.98 (q,
J = 33.4 Hz), 114.44 (s), 110.48 (s), 21.08 (s); 19F NMR (470 MHz,
CDCl3) δ -66.13 (s, 3F); GC-MS (EI, m/z): 230(M+, 26), 202(27),
43(100), 32(38).
6-Bromo-3-(trifluoromethyl)-2H-1-Benzopyran-2-one
(2m).
1
5. T. I. Verhoef, W. K. Redekop, A. K. Daly, R. M. van Schie, A. de
Boer and A. H. Maitland-van der Zee, Br. J. Clin. Pharm., 2014,
77, 626.
White powder (66.1 mg, 55%); mp 162-163 °C; H NMR (500 MHz,
CDCl3) δ 8.08 (s, 1H), 7.76 (m, 2H), 7.30 (d, J = 9.4 Hz, 1H); 13C NMR
(100 MHz, CDCl3) δ 155.29 (s), 153.65 (s), 142.16 (q, J = 3.9 Hz),
137.34 (s), 131.78 (s), 121.21 (q, J = 272.4 Hz), 118.96 (q, J = 34.2
Hz), 118.93 (s), 118.41 (s), 118.01 (s); 19F NMR (470 MHz, CDCl3) δ -
This journal is © The Royal Society of Chemistry 20xx
J. Name., 2013, 00, 1-3 | 5
Please do not adjust margins